{"name":"Yunhe Pharmaceutical (Tianjin) Co., Ltd","slug":"yunhe-pharmaceutical-tianjin-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"INR101","genericName":"INR101","slug":"inr101","indication":"Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"INR102 injection","genericName":"INR102 injection","slug":"inr102-injection","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"INR101","genericName":"INR101","slug":"inr101","phase":"phase_3","mechanism":"INR101 is an anticoagulant that works by inhibiting the synthesis of vitamin K-dependent clotting factors.","indications":["Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation"],"catalyst":""},{"name":"INR102 injection","genericName":"INR102 injection","slug":"inr102-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}